Longevity / discovery / 3 MIN READ

Rapamycin: From Transplant Drug to Longevity Bet

Early Phase-2 trials show measurable effects on immune aging. What does that mean for healthy adults?

UPDATED 2026-04-28 / TIME HORIZON · mid term / ID · 512B10C6
Rapamycin: From Transplant Drug to Longevity Bet
Reality 55 /100
Hype 60 /100
Impact 75 /100

Explanation

An old transplant medicine is being tested on thousands of healthy people. Results look promising but warrant caution.

Reality meter

Longevity Time horizon · mid term
Reality Score 55 / 100
Hype Risk 60 / 100
Impact 75 / 100
Source Quality 70 / 100
Community Confidence 50 / 100

Time horizon

Expected mid term

Community read

Community live aggregateIdle
Reality (article)55/ 100
Hype60/ 100
Impact75/ 100
Confidence50/ 100
Prediction Yes0%none yet
Prediction votes0∑

Glossary

mTOR
Central signaling pathway for cell growth and aging.
PEARL trial
Crowd-funded Phase-2 rapamycin trial.

Sources

Prediction

Will at least three Phase-3 trials of rapamycin as an anti-aging therapy be running by 2030?

Vote

Quick vote
Stars (1–5)
How real is this? Reality Ø 55
More or less of this?

Related transmissions

No related transmissions yet.